D-0668-2017 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- April 19, 2017
- Initiation Date
- March 8, 2017
- Termination Date
- August 19, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 98 vials
Product Description
hydrALAZINE HYDROCHLORIDE INJECTION, USP, 20 mg/mL, 1 mL Single Dose Vial, packaged in 25 Vials per carton, Rx only, APP Fresenius Kabi USA, LLC, Lake Surich, IL 60047, NDC 63323-614-01, Distributed by McKesson Medical-Surgical, Inc.
Reason for Recall
Temperature Abuse: Certain pieces of these lots distributed by McKesson Medical Surgical Inc. were inadvertently stored refrigerated rather than the labeled room temperature recommendation.
Distribution Pattern
Nationwide in the USA
Code Information
Lot #s: 6114311, 6114717, Exp 05/18